Vous avez cherché: mycobacterium (Anglais - Maltais)

against mycobacterium avium-
mnaqqsa kontra l-kumpless

tuberculosis due to mycobacterium bovis
it-tuberkulożi minħabba l-mycobacterium bovis

aminosalicylic acid is bacteriostatic against mycobacterium tuberculosis.
l-aminosalicylic acid huwa batterjostatiku kontra l-mycobacterium tuberculosis.

mycobacterium avium complex: clarithromycin, rifabutin, rifampicin.
ma ’ l- aids u mycobacterium avium: clarithromycin, rifabutin, rifampicin.

tuberculosis is an infection caused by the bacterium mycobacterium tuberculosis.
it-tuberkulożi hija infezzjoni kkawżata mill-batterju mycobacterium tuberculosis.

the injection of living mycobacterium bovis strain an5 in physiological saline;
l-injezzjoni ta' mycobacteriumbovisstrain ħaj an5 f'salina fiżjoloġika;

the injection of heat-killed mycobacterium bovis strain an5 in oil adjuvant;
l-injezzjoni ta' mycobacteriumbovisstrain meqruda bis-sħana an5 f' adjuvant taż-żejt;

these subjects were excluded from the subgroup analysis by extent of resistance of mycobacterium tuberculosis strain.
dawn l-individwi kienu esklużi mill-analiżi tas-sottogrupp skont il-firxa ta’ reżistenza tar-razza ta’ mycobacterium tuberculosis.

mgit® mycobacterium growth indicator tube liquid media system n= subjects with scc at 2 months
mgit® sistema tal-midja likwida li tindika Żvilupp ta’ mikobatterja fit-tubu indikatur [mycobacterium growth indicator tube liquid media system] n= individwi b’scc wara xahrejn

interference with culture test moxifloxacin therapy may give false negative culture results for mycobacterium spp. by suppression of mycobacterial growth.
14 interferenza b’ test ta ’ kultura terapija b’ moxifloxacin tista ’ tagħti riżultati tal- kultura negattivi foloz għal mycobacterium spp. permeżż ta ’ sopressjoni tat- tkabbir tal- mycobacteria.

relevant examples are cytomegalovirus retinitis, generalised and/or focal mycobacterium infections, and pneumocystis carinii pneumonia.
eżempji relevanti jinkludu retinite b’cytomegalovirus, infezzjonijiet lokali jew mifruxa b’mycobacterium, u pnewmonja b’pneumocvstis carinii.

mycobacterium xenopi, mycobacterium novocastrense, mycobacterium shimoidei and non-mycobacterial species are considered inherently resistant to bedaquiline.
mycobacterium xenopi, mycobacterium novocastrense, mycobacterium shimoidei u speċi mhux mikobatteriċi huma kkonsidrati reżistenti b’mod inerenti għal bedaquiline.

infections and malignancies causing myelosuppression neutropenia may be due to bone marrow-infiltrating opportunistic infections such as mycobacterium avium complex or malignancies such as lymphoma.
infezzjonijiet u malinni li jikkawżaw majelosoppressjoni in- newtropenja tista ’ tkun minħabba infezzjonijiet opportunistiċi li jinfiltraw il- mudullun bħall - kumpless mycobacterium avium jew malinni bħal limfoma.

211 interaction with tests the in-vitro activity of ciprofloxacin against mycobacterium tuberculosis might give false negative bacteriological test results in specimens from patients currently taking ciprofloxacin.
217 interazzjoni mat- testijiet l- attività in- vitro ta ’ ciprofloxacin kontra mycobacterium tuberculosis tista ’ tagħti riżultati negattivi foloz tat- testijiet batterjoloġiċi f’ kampjuni minn pazjenti li jkunu qed jieħdu ciprofloxacin.

medicines used to treat bacterial infections, including tuberculosis and aids-related mycobacterium avium complex: clarithromycin, rifabutin, rifampicin.
mediċini użati biex jikkuraw infezzjonijiet batterjali, inkluż tuberkolożi u kumpless ta’ avju mijobatterjum: clarithromycin, rifabutin, rifampicin.

the most frequently observed oi’s in clinical studies were candidiasis, cytomegalovirus, herpes simplex, pneumocystis carinii pneumonia, and mycobacterium avium complex.
l-iżjed oi’s frekwenti fl-istudji kliniċi kienu; kandidijażi, ċitomegalovirus, herpes simplex, pulmonite b’pneumocystis carinii u mycobacterium avium complex.

opportunistic infections and tuberculosis (including coccidioidomycosis, histoplasmosis and mycobacterium avium complex infection), bacterial infections, eye infections, diverticulitis 1)
infezzjonijiet opportunistiċi u tuberkulosi (li jinkludu coccidioidomycosis, histoplasmosis u infezzjoni tal-mycobacterium avium complex), infezzjonijiet tal-batterji, infezzjonijiet fl-għajnejn,

relevant examples are cytomegalovirus retinitis, generalised and/or focal mycobacterium infections, and pneumocystis jiroveci pneumonia (formerly known as pneumocystis carinii pneumonia).
eżempji rilevanti jinkludu retinite b’ ċitomegalovirus, infezzjonijiet mikobatterjali lokali jew mifruxa, u pulmonite b’pneumocystis jiroveci li qabel kien magħruf bħala pneumocystis carinii.

multi-drug resistant mycobacterium tuberculosis (mdrh&r-tb): isolate resistant to at least isoniazid and rifampicin, but susceptible to fluoroquinolones and second line injectable agents.
mycobacterium tuberculosis (mdrh&r-tb) reżistenti għal diversi mediċini: iżolati reżistenti għal tal-anqas isoniazid u rifampicin, imma suxxetibbli għal fluoroquinolones u sustanzi injetabbli bħala t-tieni linja ta’ preferenza.